BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34111959)

  • 1. Efficacy of low-dose radiotherapy (2 Gy × 2) in the treatment of marginal zone and mucosa-associated lymphoid tissue lymphomas.
    Cerrato M; Orlandi E; Vella A; Bartoncini S; Iorio GC; Bongiovanni D; Capriotti F; Boccomini C; Vassallo F; Cavallin C; De Luca V; Giglioli FR; Ricardi U; Levis M
    Br J Radiol; 2021 Jul; 94(1123):20210012. PubMed ID: 34111959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response rates and recurrence patterns after low-dose radiotherapy with 4 Gy in patients with low-grade lymphomas.
    König L; Hörner-Rieber J; Bernhardt D; Hommertgen A; Rieken S; Debus J; Herfarth K
    Strahlenther Onkol; 2018 May; 194(5):454-461. PubMed ID: 29450588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy of indolent orbital lymphomas : Two radiation concepts.
    König L; Stade R; Rieber J; Debus J; Herfarth K
    Strahlenther Onkol; 2016 Jun; 192(6):414-21. PubMed ID: 27160291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy of extranodal low-grade follicular and marginal zone lymphomas: long-term follow-up of 159 patients.
    Elsayad K; Reinartz G; Oertel M; Rehn S; Eismann J; Scobioala S; Berssenbrügge H; Eter N; Weishaupt C; Schmidt HH; Friedrichs B; Grünewald I; Hartmann W; Lenz G; Wardelmann E; Willich N; Eich HT
    Strahlenther Onkol; 2020 Feb; 196(2):117-125. PubMed ID: 31732783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue (MALT) Lymphoma.
    Fang P; Gunther JR; Pinnix CC; Dong W; Strati P; Nastoupil LJ; Steiner RE; Ahmed S; Damron EP; Fowler N; Nair R; Westin JR; Neelapu S; Ha CS; Dabaja BS
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1414-1420. PubMed ID: 33309978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes.
    Fung CY; Tarbell NJ; Lucarelli MJ; Goldberg SI; Linggood RM; Harris NL; Ferry JA
    Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1382-91. PubMed ID: 14630277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De-escalated radiotherapy for indolent primary cutaneous B-cell lymphoma.
    Oertel M; Elsayad K; Weishaupt C; Steinbrink K; Eich HT
    Strahlenther Onkol; 2020 Feb; 196(2):126-131. PubMed ID: 31758232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue in the oromaxillofacial head and neck region: A retrospective analysis of 105 patients.
    Zhang T; Wu Y; Ju H; Meng J; Guo W; Ren G
    Cancer Med; 2020 Jan; 9(1):194-203. PubMed ID: 31733094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare lymphomas in routine practice - Treatment and outcome in marginal zone lymphoma in the prospective German Tumour Registry Lymphatic Neoplasms.
    Knauf W; Abenhardt W; Koenigsmann M; Maintz C; Sandner R; Zahn MO; Schnell R; Tech S; Kaiser-Osterhues A; Houet L; Marschner N;
    Hematol Oncol; 2021 Aug; 39(3):313-325. PubMed ID: 33942348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage I and II MALT lymphoma: results of treatment with radiotherapy.
    Tsang RW; Gospodarowicz MK; Pintilie M; Bezjak A; Wells W; Hodgson DC; Crump M
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1258-64. PubMed ID: 11483337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project.
    Nathwani BN; Anderson JR; Armitage JO; Cavalli F; Diebold J; Drachenberg MR; Harris NL; MacLennan KA; Müller-Hermelink HK; Ullrich FA; Weisenburger DD
    J Clin Oncol; 1999 Aug; 17(8):2486-92. PubMed ID: 10561313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes and patterns of relapse of early-stage extranodal marginal zone lymphoma treated with radiation therapy with curative intent.
    Teckie S; Qi S; Lovie S; Navarrett S; Hsu M; Noy A; Portlock C; Yahalom J
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):130-7. PubMed ID: 25863760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of radiation therapy in the treatment of stage I/II mucosa-associated lymphoid tissue lymphoma.
    Tsai HK; Li S; Ng AK; Silver B; Stevenson MA; Mauch PM
    Ann Oncol; 2007 Apr; 18(4):672-8. PubMed ID: 17218489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy alone for stage IE ocular adnexal mucosa-associated lymphoid tissue lymphomas: long-term results.
    Niwa M; Ishikura S; Tatekawa K; Takama N; Miyakawa A; Kubota T; Kato E; Shibamoto Y
    Radiat Oncol; 2020 Jan; 15(1):25. PubMed ID: 32000814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective Phase II trial of radiation therapy in localised non-gastric marginal zone lymphoma with prospective evaluation of autoimmunity and Helicobacter pylori status: TROG 05.02/ALLG NHL15.
    MacManus MP; Roos D; O'Brien P; Capp A; Wirth A; Tsang R; Bressel M; Lade S; Seymour JF
    Eur J Cancer; 2021 Jul; 152():129-138. PubMed ID: 34098462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma.
    Pinnix CC; Gunther JR; Milgrom SA; Cruz Chamorro RJ; Medeiros LJ; Khoury JD; Amini B; Neelapu S; Lee HJ; Westin J; Fowler N; Nastoupil L; Dabaja B
    Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):447-455. PubMed ID: 30769175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orbital marginal zone B-cell lymphoma of MALT: radiotherapy results and clinical behavior.
    Suh CO; Shim SJ; Lee SW; Yang WI; Lee SY; Hahn JS
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):228-33. PubMed ID: 16503386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome and patterns of failure in primary ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy.
    Hashimoto N; Sasaki R; Nishimura H; Yoshida K; Miyawaki D; Nakayama M; Uehara K; Okamoto Y; Ejima Y; Azumi A; Matsui T; Sugimura K
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1509-14. PubMed ID: 21664061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term outcomes of gastric mucosa-associated lymphoid tissue lymphoma treated with radiotherapy: A multi-center retrospective cohort study.
    Smith CD; Gupta S; Sinn Chin Y; Thompson SR
    Hematol Oncol; 2023 Feb; 41(1):71-77. PubMed ID: 36150219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment effects and sequelae of radiation therapy for orbital mucosa-associated lymphoid tissue lymphoma.
    Hata M; Omura M; Koike I; Tomita N; Iijima Y; Tayama Y; Odagiri K; Minagawa Y; Ogino I; Inoue T
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1387-93. PubMed ID: 20950950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.